The effect of body mass index on optimal vitamin D status in U.S. adults: The National Health and Nutrition Examination Survey 2001-2006

Annals of Epidemiology

Volumn 23, Issue 7, 2013, Pages 409-414

  Samuel, Lalitha ^a   Borrell, Luisa N ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

25 hydroxy vitamin D; Body mass index; National Health and Nutrition Examination Survey; Race ethnicity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; DIABETES MELLITUS; FEMALE; HEALTH DISPARITY; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PREVALENCE; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84879425483     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.05.011     Document Type: Article

References (53)

1. Ginde A.A., Liu M.C., Camargo C.A. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009, 169(6):626-632.
2. Flegal K.M., Carroll M.D., Kit B.K., Ogden C.L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307(5):491-497.
3. Lagunova Z., Porojnicu A.C., Lindberg F., Hexeberg S., Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009, 29(9):3713-3720.
4. Al-Elq A.H., Sadat-Ali M., Al-Turki H.A., Al-Mulhim F.A., Al-Ali A.K. Is there a relationship between body mass index and serum vitamin D levels?. Saudi Med J 2009, 30(12):1542-1546.
5. Blum M., Dallal G.E., Dawson-Hughes B. Body size and serum 25 hydroxy vitamin D response to oral supplements in healthy older adults. JAm Coll Nutr 2008, 27(2):274-279.
6. Parikh S.J., Edelman M., Uwaifo G.I., Freedman R.J., Semega-Janneh M., Reynolds J., et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. JClin Endocrinol Metab 2004, 89(3):1196-1199.
7. Kudlacek S., Schneider B., Peterlik M., Leb G., Klaushofer K., Weber K., et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 2003, 33(4):323-331.
8. Rucker D., Allan J.A., Fick G.H., Hanley D.A. Vitamin D insufficiency in a population of healthy western Canadians. CMAJ 2002, 166(12):1517-1524.
9. Lamberg-Allardt C.J., Outila T.A., Karkkainen M.U., Rita H.J., Valsta L.M. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe?. JBone Miner Res 2001, 16(11):2066-2073.
10. Looker A.C., Pfeiffer C.M., Lacher D.A., Schleicher R.L., Picciano M.F., Yetley E.A. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008, 88(6):1519-1527.
11. Scragg R., Camargo C.A. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2008, 168(6):577-586.
12. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167(11):1159-1165.
13. Kimmons J.E., Blanck H.M., Tohill B.C., Zhang J., Khan L.K. Associations between body mass index and the prevalence of low micronutrient levels among US adults. Med Gen Med 2008, 8(4):59.
14. Zadshir A., Tareen N., Pan D., Norris K., Martins D. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005, 15(Suppl. 5):S5-S101.
15. National Health and Nutrition Examination Survey Analytic Guidelines Centers for Disease Control and Prevention, National Center for Health Statistics, [accessed 12.03.2012]. http://www.cdc.gov/nchs/nhanes/nhanes2003-2004/analytical_guidelines.htm.
16. Dietary reference intakes for calcium and vitamin D Institute of Medicine, [accessed 20.04.2012]. http://books.nap.edu/openbook.php%3frecord_id%3d13050.
17. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson- Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J. of Clin Nutr 2006, 84(1):18-28.
18. Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75nmol/L (30 ng/ml). Best Practice Res Clin Endocrinol Metab 2011, 25(4):681-691.
19. Holick M.F., Chen T.C. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008, 87(4):1080S-1086S.
20. About BMI for adults Centers for Disease Control and Prevention, [accessed on 12.02.2012]. http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html.
21. Brock K., Huang W., Fraser D., Ke L., Tseng M., Mason R., et al. Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr 2011, 106(3):339-344.
22. Schmitz K.J., Skinner H.G., Bautista L.E., Fingerlin T.E., Langefeld C.D., Hicks P.J., et al. Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am J Hyperten 2009, 22(8):867-870.
23. Botella-Carretero J.I., Alvarez-Blasco F., Villafruela J.J., Balsa J.A., Vazquez C., Escobar-Morreale H.F. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007, 26(5):573-580.
24. Salekzamani S., Neyestani T.R., Alavi-Majd H., Houshiarrad A., Kalayi A., Shariatzadeh N., et al. Is vitamin D status a determining factor for metabolic syndrome? A case-control study. Diabetes Metab Syndr Obes 2011, 4:205-212.
25. Vashi P.G., Trukova K., Lammersfeld C.A., Braun D.P., Gupta D. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology. Nutr J 2010, 9:60.
26. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000, 72(3):690-693.
27. Compston J.E., Vedi S., Ledger J.E., Webb A., Gazet J.C., Pilkington T.R. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 1981, 34(11):2359-2363.
28. McCarty M.F., Thomas C.A. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003, 61(5-6):535-542.
29. Office of Dietary Supplements. Dietary supplement fact sheet: vitamin D, ; [accessed 20.04.2012]. http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/.
30. Jorde R., Sneve M., Emaus N., Figenschau Y., Grimnes G. Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromso study. Eur J Nutr 2010, 49(7):401-407.
31. Moschonis G., Tanagra S., Koutsikas K., Nikolaidou A., Androutsos O., Manios Y. Association between serum 25-hydroxyvitamin D levels and body composition in postmenopausal women: the postmenopausal Health Study. Menopause 2009, 16(4):701-707.
32. Whiting S.J., Langlois K.A., Vatanparast H., Greene-Finestone L.S. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr 2011, 94(1):128-135.
33. Vatanparast H., Calvo M.S., Green T.J., Whiting S.J. Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. JSteroid Biochem Mol Biol 2010, 121(1-2):301-303.
34. Calvo M.S., Whiting S.J. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003, 61:107-113.
35. Calvo M.S., Whiting S.J., Barton C.N. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004, 80(Suppl. 6):1710S-1716S.
36. Harris S.S. Vitamin D and African Americans. JNutr 2006, 136(4):1126-1129.
37. MacLaughlin J., Holick M.F. Aging decreases the capacity of human skin to produce vitamin D3. JClin Invest 1985, 76(4):1536-1538.
38. McCarty C.A. Sunlight exposure assessment: can we accurately assess vitamin D exposure from sunlight questionnaires?. Am J Clin Nutr 2008, 87(40):1097S-1101S.
39. Misra M., Pacaud D., Petryk A., Collett-Solberg P.F., Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008, 122(2):398-417.
40. Holick M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79(3):362-371.
41. "Healthy People 2020," U.S. Department of Health and Human Services, [accessed 25.05.2012]. http://healthypeople.gov/2020/topicsobjectives2020/ebr.aspx?topicId=5.
42. Matsuoka L.Y., Ide L., Wortsman J., MacLaughlin J.A., Holick M.F. Sunscreens suppress cutaneous vitamin D3 synthesis. JClin Endocrinol Metab 1987, 64(6):1165-1168.
43. Cancer trends progress report-2009/2010 update National Cancer Institute, National Institutes of Health, Department of Health and Human Services, [accessed 12.07.2012]. http://progressreport.cancer.gov.
44. Boucher B.J., Witham M.D. Should we be giving enhanced vitamin D intakes to all?. JR Coll Physicians Edinb 2011, 41(4):324-329.
45. Grant W.B., Schwalfenberg G.K., Genuis S.J., Whiting S.J. An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol Nutr Food Res 2010, 54(8):1172-1181.
46. Baz-Hecht M., Goldfine A.B. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010, 17(2):113-119.
47. Mathieu C., Gysemans C., Giulietti A., Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48:1247-1257.
48. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
49. Michos E.D., Melamed M.L. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care 2008, 11(1):7-12.
50. Dall T.M., Zhang Y., Chen Y.J., Quick W.W., Yang W.G., Fogli J. The economic burden of diabetes. Health Affairs 2010, 29(20):297-303.
51. Heidenreich P.A., Trogdon J.G., Khavjou O.A., Butler J., Dracup K., Ezekowitz M.D., et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011, 123(8):933-944.
52. Snijder M.B., van Dam R.M., Visser M., Deeg D.J., Dekker J.M., Bouter L.M., et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. JClin Endocrinol Metab 2005, 90(7):4119-4123.
53. Norman A.W. Avitamin D nutritional: new insights concerning the serum 25-hydroxyvitamin D status of the US population. Am J Clin Nutr 2008, 88(6):1455-1456.